Revista Panamericana de Salud Publica-Pan American Journal of Public H

Papers
(The H4-Index of Revista Panamericana de Salud Publica-Pan American Journal of Public H is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Effects of the COVID-19 pandemic on food insecurity in El Salvador during 2020103
Taxation of novel and emerging nicotine and tobacco products (HTPs, ENDS, and ENNDS) globally and in Latin America48
Barreras y facilitadores a la implementación de la telemedicina en las Américas38
Observatorios sociales nacionales y regional de tuberculosis en ocho países de Latinoamérica y el Caribe33
Sistemas de información y documentación regulatoria de El Salvador referido a migración y salud30
Concerning “The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care”27
Corrigendum a La violencia por parte de la pareja íntima en las Américas: una revisi0ón sistemática y reanálisis de las estimaciones nacionales de prevalencia25
The SickKids Caribbean Initiative to improve care for children with cancer and blood disorders20
Control de equinococosis quística: perspectivas en el siglo XXI20
Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina19
Síntesis de evidencia y recomendaciones: directrices para la profilaxis antibiótica y la elección de antisépticos en las mujeres con parto vaginal instrumentado o cesárea19
La COVID-19 en Colombia y Venezuela: dos caras de la misma moneda18
Tobacco industry strategies to influence the regulation of new and emerging tobacco and nicotine products in Latin America and the Caribbean16
Addressing malnutrition in all its forms in Caribbean countries using a food systems approach15
Timely initiation of HIV antiretroviral therapy in Haiti 2004–2018: a retrospective cohort study15
Homologación de vacunas contra la COVID-19: experiencia y desafíos desde su implementación en Chile15
0.24706101417542